BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 11861292)

  • 1. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.
    Zhan F; Hardin J; Kordsmeier B; Bumm K; Zheng M; Tian E; Sanderson R; Yang Y; Wilson C; Zangari M; Anaissie E; Morris C; Muwalla F; van Rhee F; Fassas A; Crowley J; Tricot G; Barlogie B; Shaughnessy J
    Blood; 2002 Mar; 99(5):1745-57. PubMed ID: 11861292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development.
    Zhan F; Tian E; Bumm K; Smith R; Barlogie B; Shaughnessy J
    Blood; 2003 Feb; 101(3):1128-40. PubMed ID: 12393520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
    Pichiorri F; Suh SS; Ladetto M; Kuehl M; Palumbo T; Drandi D; Taccioli C; Zanesi N; Alder H; Hagan JP; Munker R; Volinia S; Boccadoro M; Garzon R; Palumbo A; Aqeilan RI; Croce CM
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12885-90. PubMed ID: 18728182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.
    Davies FE; Dring AM; Li C; Rawstron AC; Shammas MA; O'Connor SM; Fenton JA; Hideshima T; Chauhan D; Tai IT; Robinson E; Auclair D; Rees K; Gonzalez D; Ashcroft AJ; Dasgupta R; Mitsiades C; Mitsiades N; Chen LB; Wong WH; Munshi NC; Morgan GJ; Anderson KC
    Blood; 2003 Dec; 102(13):4504-11. PubMed ID: 12947006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic abnormalities in monoclonal gammopathy of undetermined significance.
    Fonseca R; Bailey RJ; Ahmann GJ; Rajkumar SV; Hoyer JD; Lust JA; Kyle RA; Gertz MA; Greipp PR; Dewald GW
    Blood; 2002 Aug; 100(4):1417-24. PubMed ID: 12149226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs.
    Taylor BJ; Reiman T; Pittman JA; Keats JJ; de Bruijn DR; Mant MJ; Belch AR; Pilarski LM
    J Immunother; 2005; 28(6):564-75. PubMed ID: 16224274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.
    Mylin AK; Rasmussen T; Johansen JS; Knudsen LM; Nørgaard PH; Lenhoff S; Dahl IM; Johnsen HE;
    Eur J Haematol; 2006 Nov; 77(5):416-24. PubMed ID: 16930142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
    Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
    Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16(INK4a) and p15(INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance.
    Guillerm G; Gyan E; Wolowiec D; Facon T; Avet-Loiseau H; Kuliczkowski K; Bauters F; Fenaux P; Quesnel B
    Blood; 2001 Jul; 98(1):244-6. PubMed ID: 11418489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
    Anguiano A; Tuchman SA; Acharya C; Salter K; Gasparetto C; Zhan F; Dhodapkar M; Nevins J; Barlogie B; Shaughnessy JD; Potti A
    J Clin Oncol; 2009 Sep; 27(25):4197-203. PubMed ID: 19636021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Almeida J; Orfao A; Mateo G; Ocqueteau M; García-Sanz R; Moro MJ; Hernandez J; Ortega F; Borrego D; Barez A; Mejido M; San Miguel JF
    Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells.
    Croonquist PA; Linden MA; Zhao F; Van Ness BG
    Blood; 2003 Oct; 102(7):2581-92. PubMed ID: 12791645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
    Zhan F; Barlogie B; Arzoumanian V; Huang Y; Williams DR; Hollmig K; Pineda-Roman M; Tricot G; van Rhee F; Zangari M; Dhodapkar M; Shaughnessy JD
    Blood; 2007 Feb; 109(4):1692-700. PubMed ID: 17023574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
    J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.
    Rasmussen T; Theilgaard-Mönch K; Hudlebusch HR; Lodahl M; Johnsen HE; Dahl IM
    Br J Haematol; 2003 Oct; 123(2):253-62. PubMed ID: 14531906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
    Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
    Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.
    Fagerli UM; Holt RU; Holien T; Vaatsveen TK; Zhan F; Egeberg KW; Barlogie B; Waage A; Aarset H; Dai HY; Shaughnessy JD; Sundan A; Børset M
    Blood; 2008 Jan; 111(2):806-15. PubMed ID: 17934070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.